HealthHonors' Innovative Technology Platform Adopted By AstraZeneca - Program Will Help Patients Take Their Medicines As Prescribed HealthHonors® today announced that AstraZeneca Pharmaceuticals LP has implemented HealthHonors' proprietary technology platform to help patients remember to take their medicine as prescribed. The HealthHonors platform, known as Dynamic Intermittent Reinforcement (DIR™), is a patient incentive program that uses intermittent reinforcement schedules to motivate patients to take their medications as prescribed.
Source: www.medicalnewstoday.comPharmaceutical Safety Company Shares Insight Into European Quality Assurance Regulations Drug Safety Alliance (DSA), a global leader in pharmaceutical safety and pharmacovigilance, was invited to share their extensive insight into quality assurance protocols in Europe with the Regulatory Affairs Professionals Society (RAPS) at their annual conference held recently in Boston.
Source: www.medicalnewstoday.comTopical Anesthetics Patients, healthcare professionals, and caregivers alerted to serious hazards of using skin numbing products for relieving pain from mammography and other medical tests and conditions, especially when applied to a large area of skin or when the area of application is covered.
Source: www.fda.gov
# posted by Network @ 10:35 AM
